Larimar Therapeutics (LRMR) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Larimar Therapeutics (LRMR) Company Statistics | The Fly

Larimar Therapeutics

· LRMR

Dashboard

Financials

Ratios

Valuation

Statistics

326.192 M

+1.75%

General

Market Cap: $326.19M
Enterprise Value: $244.18M
Shares Outstanding: 103,880,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -104.42%
ROE: -137.39%
ROIC: -135.25%
Current Ratio: 4.70
Debt-to-Equity: 0.04
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.06
P/S: —
P/FCF: —
P/B: 2.61
EV/EBITDA: -1.42

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $178.99M
Operating Income: -$178.99M
Net Profit: -$172.61M

Balance Sheet

Cash and Equivalents: $92.69M
Working Capital: $126.51M
Total Assets: $165.3M
Net Debt: -$87.73M
Total Liabilities: $37.92M
Total Equity: $127.38M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$155.92M
Cash Flow from Investing: $55.11M
Cash Flow from Financing: $172.77M
Free Cash Flow: -$156.08M
Capital Expenditures: $153K